Regulation of human P2Y1-like G protein-coupled receptor
AssigneeActimis Pharmaceuticals, Inc.
InventorShyam Ramakrishnan
Life of this patent
Estimating the term…
Loading patent…
AssigneeActimis Pharmaceuticals, Inc.
InventorShyam Ramakrishnan
Estimating the term…
Reagents which regulate human P2Y1-like G protein-coupled receptor can play a role in preventing, ameliorating, or correcting dysfunctions or diseases including, but not limited to, infections such as bacterial, fungal, protozoan, and viral infections, particularly those caused by HIV viruses, pain, cancers, anorexia, bulimia, asthma, CNS diseases such as Parkinson's disease, acute heart failure, hypotension, hypertension, urinary retention, osteoporosis, diabetes, angina pectoris, myocardial infarction, ulcers, asthma, inflammation, allergies, multiple sclerosis, benign prostatic hypertrophy, and psychotic and neurological disorders, including anxiety, schizophrenia, manic depression, delirium, dementia, several mental retardation, and dyskinesias, such as Huntington's disease and Tourett's syndrome.
1-35. (canceled)
A method of screening for agents which can modulate the activity of a human P2Y1-like GPCR, comprising the steps of:
37-71. (canceled)
Dependencies are inferred from the claim text.